What is Velocity Pharma?
Velocity Pharma operates as a specialized contract manufacturer, providing end-to-end production services for the nutritional products industry. The firm distinguishes itself through a commitment to rigorous FDA-mandated c-GMP guidelines, ensuring that every dosage form and packaging configuration meets stringent quality standards. By acting as a strategic partner rather than a mere vendor, Velocity Pharma integrates itself into the product lifecycle of its clients, offering a comprehensive lifeline for brand development and manufacturing excellence. Their expertise spans a diverse array of supplement formats, allowing them to navigate the complexities of the ever-expanding wellness market with precision and technical agility.
How much funding has Velocity Pharma raised?
Velocity Pharma has raised a total of $74K across 1 funding round:
Debt
$74K
Debt (2021): $74K with participation from PPP
Key Investors in Velocity Pharma
PPP
Public-Private Partnership
What's next for Velocity Pharma?
With the recent capital deployment, Velocity Pharma is poised to transition into a more aggressive growth phase, focusing on the optimization of its manufacturing facilities and the expansion of its service portfolio. The company intends to utilize this financing to enhance its technical infrastructure, thereby supporting the development of more complex and innovative nutritional items. As the firm continues to refine its private-label capabilities, the focus will remain on maintaining operational excellence while scaling to accommodate a broader client base. This strategic trajectory suggests a long-term commitment to becoming a dominant force in the contract manufacturing landscape, driven by both technical proficiency and a robust financial foundation.
See full Velocity Pharma company page
